BIOMAT Database Logo BIOMAT Database Logo

Deep brain stimulation and cognition in Parkinson's disease: an eight-year follow-up study. 2012

Roberta Zangaglia, and Chiara Pasotti, and Francesca Mancini, and Domenico Servello, and Elena Sinforiani, and Claudio Pacchetti

UI MeSH Term Description Entries
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014705 Verbal Behavior Includes both producing and responding to words, either written or spoken. Behavior, Verbal,Behaviors, Verbal,Verbal Behaviors
D046690 Deep Brain Stimulation Therapy for MOVEMENT DISORDERS, especially PARKINSON DISEASE, that applies electricity via stereotactic implantation of ELECTRODES in specific areas of the BRAIN such as the THALAMUS. The electrodes are attached to a neurostimulator placed subcutaneously. Brain Stimulation, Deep,Electrical Stimulation of the Brain,Brain Stimulations, Deep,Deep Brain Stimulations,Stimulation, Deep Brain,Stimulations, Deep Brain
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease
D020531 Subthalamic Nucleus Lens-shaped structure on the inner aspect of the INTERNAL CAPSULE. The SUBTHALAMIC NUCLEUS and pathways traversing this region are concerned with the integration of somatic motor function. Nucleus Subthalamicus,Body of Luys,Corpus Luysi,Nucleus of Luys,Subthalamic Nucleus of Luys,Luys Body,Luys Nucleus,Luys Subthalamic Nucleus,Luysi, Corpus,Nucleus, Subthalamic,Subthalamicus, Nucleus

Related Publications

Roberta Zangaglia, and Chiara Pasotti, and Francesca Mancini, and Domenico Servello, and Elena Sinforiani, and Claudio Pacchetti
Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease.
November 2003, Movement disorders : official journal of the Movement Disorder Society,
Roberta Zangaglia, and Chiara Pasotti, and Francesca Mancini, and Domenico Servello, and Elena Sinforiani, and Claudio Pacchetti
Intracranial hemorrhage risk factors of deep brain stimulation for Parkinson's disease: a 2-year follow-up study.
May 2020, The Journal of international medical research,
Roberta Zangaglia, and Chiara Pasotti, and Francesca Mancini, and Domenico Servello, and Elena Sinforiani, and Claudio Pacchetti
Gait initiation evaluation after deep brain stimulation for Parkinson's disease: A 7-year follow-up.
January 2010, Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference,
Roberta Zangaglia, and Chiara Pasotti, and Francesca Mancini, and Domenico Servello, and Elena Sinforiani, and Claudio Pacchetti
Follow-up of bilateral subthalamic deep brain stimulation for Parkinson's disease.
January 2006, Acta neurochirurgica. Supplement,
Roberta Zangaglia, and Chiara Pasotti, and Francesca Mancini, and Domenico Servello, and Elena Sinforiani, and Claudio Pacchetti
Eight-year follow-up study of bromocriptine monotherapy for Parkinson's disease.
January 1996, European neurology,
Roberta Zangaglia, and Chiara Pasotti, and Francesca Mancini, and Domenico Servello, and Elena Sinforiani, and Claudio Pacchetti
Effect of unilateral subthalamic deep brain stimulation in highly asymmetrical Parkinson's disease: 7-year follow-up.
November 2018, Journal of neurosurgery,
Roberta Zangaglia, and Chiara Pasotti, and Francesca Mancini, and Domenico Servello, and Elena Sinforiani, and Claudio Pacchetti
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
October 2005, Brain : a journal of neurology,
Roberta Zangaglia, and Chiara Pasotti, and Francesca Mancini, and Domenico Servello, and Elena Sinforiani, and Claudio Pacchetti
Quality of life and depressive symptoms in Parkinson's disease after subthalamic deep brain stimulation: a 2-year follow-up study.
January 2013, Turkish neurosurgery,
Roberta Zangaglia, and Chiara Pasotti, and Francesca Mancini, and Domenico Servello, and Elena Sinforiani, and Claudio Pacchetti
Acute Effects of Subthalamic Deep Brain Stimulation on Motor Outcomes in Parkinson's Disease; 13 Year Follow Up.
January 2019, Frontiers in neurology,
Roberta Zangaglia, and Chiara Pasotti, and Francesca Mancini, and Domenico Servello, and Elena Sinforiani, and Claudio Pacchetti
Eight-year follow-up outcome of subthalamic deep brain stimulation for Parkinson's disease: Maintenance of therapeutic efficacy with a relatively low levodopa dosage and stimulation intensity.
November 2021, CNS neuroscience & therapeutics,
Copied contents to your clipboard!